Markets regulator Sebi is likely to reopen an insider trading case against Sun Pharmaceutical Industries as well as probe alleged lapses by some of its promoters and other entities in raising funds overseas, sources said.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2zAoo3L
0 comments:
Post a Comment